Boundless Bio, Inc. (BOLD)
2.32
-0.06
(-2.52%)
USD |
NASDAQ |
Nov 20, 16:00
2.32
0.00 (0.00%)
After-Hours: 20:00
Boundless Bio Net Income (Quarterly) : -5.364M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -5.364M |
| June 30, 2026 | -23.69M |
| March 31, 2026 | -13.56M |
| December 31, 2025 | -12.88M |
| September 30, 2025 | -13.88M |
| June 30, 2025 | -15.68M |
| March 31, 2025 | -15.76M |
| December 31, 2024 | -16.45M |
| September 30, 2024 | -16.51M |
| Date | Value |
|---|---|
| June 30, 2024 | -16.98M |
| March 31, 2024 | -15.43M |
| December 31, 2023 | -12.14M |
| September 30, 2023 | -13.17M |
| June 30, 2023 | -12.40M |
| March 31, 2023 | -11.72M |
| December 31, 2022 | -11.78M |
| September 30, 2022 | -13.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | -0.311M |
| Savara, Inc. | -42.99M |
| Arrowhead Pharmaceuticals, Inc. | -428.88M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.364M |
| EPS Diluted (Quarterly) | -0.2346 |
| Enterprise Value | -9.281M |
| Earnings Yield | -106.5% |
| Normalized Earnings Yield | -106.47 |